Quantcast

Latest Rheumatology Stories

2014-05-12 08:33:39

Arthritis Foundation Raises Funds for a Cure in the Memphis Walk to Cure Arthritis MEMPHIS, Tenn., May 12, 2014 /PRNewswire/ -- Help find a cure by participating in and fundraising for the 2014 Walk to Cure Arthritis on June 7 at Shelby Farms Park in Memphis. Formerly Arthritis Walk, Walk to Cure Arthritis is the Arthritis Foundation's signature, national fundraising event to prevent, control and cure the nation's leading cause of disability....

2014-05-09 23:01:40

Fitness equipment manufacturer Stamina Products, an Arthritis Foundation Ease-of-Use Commendation recipient, commits donation to Arthritis research for every Avari® Programmable Magnetic Elliptical sold in May. Springfield, MO (PRWEB) May 09, 2014 Stamina Products, Inc.® recently announced it has committed to the “Millions in May” campaign, which benefits the Arthritis Foundation®. Stamina Products is joining other Arthritis Foundation sponsors, donors, and corporate...

2014-05-05 23:03:36

In recognition of National Arthritis Awareness Month, CarePoint Health has partnered with the Arthritis Foundation and is pleased to present the next event in the Lunch and Learn free lecture series: “Healthy Eating and Arthritis”. Hudson County, NJ (PRWEB) May 05, 2014 In recognition of National Arthritis Awareness Month, CarePoint Health has partnered with the Arthritis Foundation and is pleased to present the next event in the Lunch and Learn free lecture series: “Healthy Eating...

2014-05-05 08:30:03

- Significant clinical response to Acthar was observed in patients experiencing active disease while on conventional SLE maintenance therapies - ANAHEIM, Calif., May 5, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that results from the first modern clinical study examining the use of H.P. Acthar® Gel (repository corticotropin injection) in systemic lupus erythematosus (SLE) has been published in the journal LUPUS. This independent investigator-initiated...

2014-05-05 00:21:27

COVA322 is First of Covagen's Bispecific FynomAbs to Enter Clinical Trials ZURICH-SCHLIEREN, Switzerland, May 5, 2014 /PRNewswire/ -- Covagen today announced it has initiated a Phase Ib/IIa study with COVA322, a bispecific TNF/IL-17A inhibitor. COVA322 is Covagen's lead bispecific FynomAb® developed for treatment of patients with rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases. The trial will enroll 39 patients with psoriasis and evaluate safety as well as...

2014-05-02 23:05:37

Orthopedic surgeons at La Peer Health Systems’ Knee Surgery Center of Excellence in Los Angeles discuss new evidence that milk helps hold off osteoarthritis of the knee. Beverly Hills, CA (PRWEB) May 02, 2014 According to new research published by the American College of Rheumatology, women who make a habit of consuming low-fat or fat-free milk show a slower progression of knee osteoarthritis. The study also found that women who consume cheese experience faster onset of the disease....

2014-05-01 08:36:11

ATLANTA, May 1, 2014 /PRNewswire-USNewswire/ -- Shopping for arthritis-related products just got easier. Today, in conjunction with Arthritis Month, the Arthritis Foundation announced that CVS/pharmacy has become the only drugstore to receive the Arthritis Foundation's 'Partner for Better Living' designation. This new distinction from the Arthritis Foundation, the nation's trusted authority on arthritis, recognizes CVS as a company that is committed to addressing the needs of people...

2014-05-01 08:31:52

VANCOUVER, May 1, 2014 /CNW/ - Successful organizations are paying more attention to the needs of employees living with arthritis, underlining the significant role 4.6 million Canadians living with arthritis have in the work force and economy. Today at the 2014 Canadian Life and Health Insurance of Canada Annual Claims Conference in Quebec City, Arthritis Consumer Experts (ACE) announced a nationwide search for best arthritis strategies and practices in the Canadian workplace as...

2014-04-30 23:22:33

Hemen Ee has discovers two alternative treatment methods for hyperuricemia and he announces his discovery to the public. Kuala Lumpur, Malaysia (PRWEB) April 30, 2014 Hyperuricemia, more commonly known as gout is a form of arthritis that occurs when uric acids build up in the blood, causing painful inflammation of the joints. In recent decades, gout has become more common, affecting between 1-2 percent of the Western population at some point during their lives. The increase in this...

2014-04-30 12:30:11

Expert Opinion Indicates That Humira and Cimzia Have the Best Clinical Profiles of Key Marketed Therapies, According to Findings from Decision Resources Group BURLINGTON, Mass., April 30, 2014 /PRNewswire/ --Decision Resources Group finds that, when asked to select the top three most persuasive end points when prescribing a new drug for psoriatic arthritis (PsA), the highest percentages of surveyed United States and European rheumatologists selected the American College of Rheumatology (ACR)...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related